Procavea Biotech

Procavea Biotech is at the forefront of biotechnology research, dedicated to revolutionizing RNA-based drug delivery to non-liver tissues. Located in Zurich, Procavea Biotech is developing innovative nonviral protein cages designed as carriers for RNA therapeutics. These cutting-edge solutions aim to enhance the precision and efficacy of drug delivery, targeting specific tissues within the body.

With a focus on protein engineering and RNA delivery, Procavea Biotech is committed to advancing the field of biotechnology. The company's primary address is c/o ETH Zurich, Vladimir-Prelog-Weg 1-5/10, HCI D 151.1/2, Zurich, Zurich 8093, CH. Procavea Biotech leverages its expertise to create groundbreaking therapies that address critical medical needs.

Procavea Biotech is dedicated to pushing the boundaries of biotechnology and improving patient outcomes through advanced RNA delivery technologies. We invite the manager of Procavea Biotech to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovative work.